Alkem Labs launches generic anti-epileptic drug in India, Well being Information, ET HealthWorld

Alkem Labs launches generic anti-epileptic drug in India Drug agency Alkem Laboratories on Monday mentioned it has launched a generic anti-epileptic drug in India to make epilepsy therapy extra accessible and reasonably priced. The drug has been launched underneath the model title ‘Brivasure’.

The corporate, “has launched the drug out there at worth, Brivasure 25mg – Rs 79.50/strip, Brivasure 50mg – Rs 148.50/strip, Brivasure 75mg – Rs 230/strip, Brivasure 100mg – Rs 295/strip, put up patent expiry of innovator product, of Brivaracetam as on February 21, 2021,” Alkem Labs mentioned in a BSE submitting.

“With the launch of Brivasure, we intention to make the therapy of Epilepsy simply accessible to the sufferers at reasonably priced pricing,” Alkem Laboratories, Persistent Enterprise President Yogesh Kaushal mentioned.

Shares of Alkem Laboratories Ltd settled at Rs 2,714.65 per scrip on BSE, down 2.08 per cent over earlier shut.



Source link